Investing.com - Biondvax Pharma ADR reported on Wednesday first quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Biondvax Pharma ADR announced earnings per share of ₪-0.005 on revenue of ₪0.00. Analysts polled by Investing.com anticipated EPS of ₪-0.17 on revenue of ₪0.00.
Biondvax Pharma ADR shares are down 42.55% from the beginning of the year and are trading at ₪1.350 , down-from-52-week-high.They are under-performing the Nasdaq which is down 22.46% from the start of the year.
Biondvax Pharma ADR shares gained 0.75% in intra-day trade the report.
Biondvax Pharma ADR follows other major Healthcare sector earnings this month
Biondvax Pharma ADR's report follows an earnings beat by Pfizer on Tuesday, May 3, 2022, who reported EPS of ₪1.62 on revenue of ₪25.66B, compared to forecasts EPS of ₪1.49 on revenue of ₪24.1B.
Medtronic had missed expectations on Thursday, May 26, 2022 with fourth quarter EPS of ₪1.52 on revenue of ₪8.09B, compared to forecast for EPS of ₪1.56 on revenue of ₪8.43B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar